Neurosciences

< Back

Overview

The Neuroscience area is consolidating its position as one of the largest clusters of research labs working on neurological diseases across Europe. At present, the area comprises 14 groups with more than one hundred fully dedicated researchers in close contact with top clinicians in the hospital. These research groups pursue a better and multifaceted understanding of the etiopathogenic mechanisms underlying a large variety of mostly adult but also pediatric neurological disorders including stroke, multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, primary headaches, epilepsy, neuromuscular disorders, and also neurosurgical and psychiatric pathologies. The area also integrates groups involved in neuroimaging, analysis and interpretation of high-throughput data, and gene therapy strategies to target inflammatory and neurodegenerative neurological conditions.

Publications

276
total
1952
impact factor
7.07
average impact factor

Group Leader: Miguel Chillón Rodríguez

Relevant advances: patent PCT/IL2019/050913, and TECNIO accreditation as a technology developer. Start of 2 new research lines, in progeria with Dr. Merce Pallàs (UB), and in spastic paraparesis 52 with “La lucha de Abril” Foundation. New recruitments: 2 PhD students, M.Martos and J.Esandi, and 2 technicians, L.Rubio and M.Cabrera. Results have been disseminated in different meetings (ASGCT, ESGCT, IARC, etc). Also, I have been co-responsible for a course in the Master of Biochemistry (UAB), and have participated in numerous masters, seminars and talks. Projects: start of the ELA International #2018-0512; Marato TV3 #201607.10 is still in progress and the Advanced-RIS3CAT #15-1-0013-16 has ended. Meanwhile, the UPV has renewed the ISO9001:2015 certification and has consolidated the good results of 2018. Relevant news, appointments in the Committee of Innovation and Transfer (VHIR), in the Direction Board of the Institute of Neurosciences (UAB), and in the Scientific Board of Biointaxis

VHIR Annual Report 2019